Saturday, May 28, 2022
  • English
  • Marathi
No Result
View All Result
Daily PRABHAT
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
    • Health
    • Lifestyle
    • Technology
    • Science
Daily PRABHAT
No Result
View All Result
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
Home Headlines

Good News : Researchers identify potential new treatment for COVID-19

by Digital Desk
7 months ago
in Headlines, International, Top News
A A
WORRYING : 36,446 new COVID-19 cases, 1,106 fatalities in Russia
Share on FacebookShare on Twitter

Canterbury [UK] – Researchers during a recent study identified a potential new treatment that suppresses the replication of SARS-CoV-2, the virus that causes Covid-19.

In order to multiply, all viruses, including coronaviruses, infect cells and reprogramme them to produce novel viruses. The study ‘Targeting the pentose phosphate pathway for SARS-CoV-2 therapy’ has been published by the scientific journal Metabolite.

The research revealed that cells infected with SARS-CoV-2 can only produce novel coronaviruses when their metabolic pentose phosphate pathway is activated.

When applying the drug benfooxythiamine, an inhibitor of this pathway, SARS-CoV-2 replication was suppressed and infected cells did not produce coronaviruses.

The research from the University of Kent’s School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, found the drug also increased the antiviral activity of ‘2-deoxy-D-glucose’; a drug which modifies the host cell’s metabolism to reduce virus multiplication.

This shows that pentose phosphate pathway inhibitors like benfooxythiamine are a potential new treatment option for COVID-19, both on their own and in combination with other treatments.

Additionally, Benfooxythiamin’s antiviral mechanism differs from that of other COVID-19 drugs such as remdesivir and molnupiravir. Therefore, viruses resistant to these may be sensitive to benfooxythiamin.

Professor Martin Michaelis, University of Kent, said, “This is a breakthrough in the research of COVID-19 treatment. Since resistance development is a big problem in the treatment of viral diseases, having therapies that use different targets is very important and provides further hope for developing the most effective treatments for COVID-19.”

“Targeting virus-induced changes in the host cell metabolism is an attractive way to interfere specifically with the virus replication process,” added Professor Jindrich Cinatl from Goethe-University Frankfurt

Tags: covid 19international
ShareTweetSendShareSend

Latest News

Another plea challenging Places of Worship Act 1991 filed in Supreme Court

I-T Dept raids at Shree Anandhaas Group of Hotels in Coimbatore

88 pc of adult population in India fully vaccinated against COVID

Champawat by-poll: Yogi Adityanath campaigns for Uttarakhand CM Dhami, holds massive raodshow

On Veer Savarkar’s birth anniversary, Randeep Hooda shares first look from freedom fighter’s biopic

IPL 2022: Sangakkara hails RR’s McCoy for ‘superb commitment’

RCB’s Siraj registers record of conceding most sixes in IPL season

Global Excellence Awards 2022 held successfully with chief guest Anupam Kher

Belarus to create militias to beef up defense

Sri Lanka: PM Wickremesinghe says USD 600 million needed to ensure supply of fertilizers

Canterbury [UK] - Researchers during a recent study identified a potential new treatment that suppresses the replication of SARS-CoV-2, the virus that causes Covid-19. In order to multiply, all viruses, including coronaviruses, infect cells and reprogramme them to produce novel viruses. The study 'Targeting the pentose phosphate pathway for SARS-CoV-2 therapy' has been published by the scientific journal Metabolite. The research revealed that cells infected with SARS-CoV-2 can only produce novel coronaviruses when their metabolic pentose phosphate pathway is activated. When applying the drug benfooxythiamine, an inhibitor of this pathway, SARS-CoV-2 replication was suppressed and infected cells did not produce coronaviruses. The research from the University of Kent's School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, found the drug also increased the antiviral activity of '2-deoxy-D-glucose'; a drug which modifies the host cell's metabolism to reduce virus multiplication. This shows that pentose phosphate pathway inhibitors like benfooxythiamine are a potential new treatment option for COVID-19, both on their own and in combination with other treatments. Additionally, Benfooxythiamin's antiviral mechanism differs from that of other COVID-19 drugs such as remdesivir and molnupiravir. Therefore, viruses resistant to these may be sensitive to benfooxythiamin. Professor Martin Michaelis, University of Kent, said, "This is a breakthrough in the research of COVID-19 treatment. Since resistance development is a big problem in the treatment of viral diseases, having therapies that use different targets is very important and provides further hope for developing the most effective treatments for COVID-19." "Targeting virus-induced changes in the host cell metabolism is an attractive way to interfere specifically with the virus replication process," added Professor Jindrich Cinatl from Goethe-University Frankfurt
No Result
View All Result
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
    • Health
    • Lifestyle
    • Technology
    • Science